WASHINGTON - Earlier this month Danaher Corp. announced a merger agreement with Beckman-Coulter, which has a fleet of 1,750 vehicles. Beckman Coulter would become part of Danaher’s Life Sciences & Diagnostics segment, joining Danaher’s Leica, AB Sciex, Radiometer, and Molecular Devices businesses.
Beckman Coulter’s Director of Corporate Communications Mary Luthy says it’s too early to say how the merger will affect the company’s fleet operations.
With annual revenues of approximately $3.7 billion, Beckman Coulter develops, manufactures and markets products for biomedical testing. Its diagnostic systems are found in hospitals and other clinical settings around the world and produce information used by physicians to diagnose disease, make treatment decisions and monitor patients. Scientists use its life science research instruments to study biological problems, including causes of disease and potential new therapies or drugs.